High pancreatic-specific lipase after Maropitant (Cerenia) in dogs

89 reports to the FDA describe high pancreatic-specific lipase in dogs given Maropitant. That is 0.7% of all reports for this medicine, compared with 0.1% across reports for all dog medicines, so it is reported unusually often with this medicine.

89Reports

90%Marked serious

3.4%Recovered

40%Died or euthanised

4 daysTypical onset

How soon it started

Same day

22 28%

1–2 days

14 18%

3–7 days

13 17%

1–4 weeks

13 17%

Over a month

16 21%

How the animals did

Recovered

3 3.4%

Still unwell when reported

42 47%

Died

19 21%

Euthanised

17 19%

Not known

8 9.0%

Problems reported at the same time

61 69%

58 65%

52 58%

49 55%

39 44%

34 38%

33 37%

28 31%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Maropitant prevents vomiting and motion sickness.

Products with this ingredient include Cerenia. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Maropitant cause high pancreatic-specific lipase in dogs?: 89 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 4 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

All reported side effects of Maropitant in dogs · Medicines most reported with high pancreatic-specific lipase